Insulin Ultralente Ho-S

Insulin Ultralente "HO-S": long-acting insulin for effective control of diabetes mellitus

In the modern world, diabetes has become one of the most common chronic diseases, affecting millions of people around the world. This disease requires constant monitoring of blood glucose levels and proper insulin management. One of the key medications for patients with diabetes is insulin Ultralente "XO-S".

Insulin Ultralente "HO-S" belongs to the group of long- and extra-long-acting insulins. It is produced in Poland at the Tarchominsk pharmaceutical plant SA Polfa. This insulin has the international name Insulin-DlD and is a widely used drug for controlling diabetes mellitus.

Insulin Ultralente "HO-S" has various synonyms, such as Insulin Superlente, Insulin Ultralente, Insulin Ultralente "VO-S", Insulin Ultralente MC, Insulin-Long SMK, Insulin-Long SMP, Insulin-Long suspension, Insulin-Ultralong SMK , Insulin-Ultralong SMP, Insulin-Ultralong suspension and Humulin Ultralente. This is due to the different trade and brand names used in different countries.

Insulin Ultralente "XO-S" is an injection suspension containing 400 IU (international units) of insulin. It provides long-lasting action and allows patients to control blood glucose levels over a long period of time. Thanks to its formula and special properties, Ultralente XO-S insulin helps stabilize sugar levels in the body, preventing sharp fluctuations and providing more predictable glycemic control.

The use of insulin Ultralente "HO-S" requires appropriate training and prescription from a doctor. The dosage and regimen of insulin should be individualized depending on the needs of each patient. Regularly monitoring your blood glucose levels and following your doctor's recommendations will help you achieve optimal diabetes control.

Insulin Ultralente "HO-S" is a high quality product produced in a modern pharmaceutical plant in Poland. The manufacturing country, Poland, is known for its high standards of drug production. Tarkhomana Pharmaceutical Plant SA Polfa is one of the leading insulin manufacturers in the region and ensures strict quality control at all stages of production.

Insulin Ultralente "HO-S" has a wide range of applications and can be recommended by a doctor for patients with various types of diabetes. It is intended to be used in combination with other types of insulin or other medications to achieve optimal blood glucose control.

It is important to note that the use of Ultralente "HO-S" insulin should be carried out under the supervision of a physician and in accordance with the individual needs of the patient. Insulin dosage may vary for each patient and must be determined by a physician based on multiple factors such as blood glucose levels, physical activity, diet, and other medical conditions.

In conclusion, insulin Ultralente "XO-S" is an important drug for the control of diabetes mellitus. It provides long-lasting action and helps patients maintain stable blood glucose levels. However, before starting to use this drug, you should consult with your doctor to determine the most effective dosage and regimen to suit each patient's individual needs.